A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma
Journal article published in 2021 by
Hans C. Lee 
,
Lei Feng,
Onyeka Oriabure,
Vivian Graham,
Wendy Chen,
Maria Badillo,
Rebecca Lu,
Hun J. Lee,
Preetesh Jain ,
Elisabet E. Manasanch ,
Robert Z. Orlowski,
Michael L. Wang
,
Lei Feng,
Onyeka Oriabure,
Vivian Graham,
Wendy Chen,
Maria Badillo,
Rebecca Lu,
Hun J. Lee,
Preetesh Jain ,
Elisabet E. Manasanch ,
Robert Z. Orlowski,
Michael L. Wang
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 